Japan approves world-first iPS cell therapies for heart failure, Parkinsons Conditional approvals speed Japans first iPS treatments into clinics for heart failure and Parkinsons ...

Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

On 6 March 2026, Japan approved the world’s first iPS stem cell treatments for Parkinson’s and severe heart failure. Could ...

Sepsis remains a major challenge in modern medicine, claiming millions of lives each year. For decades, clinical management has largely focused on suppressing excessive inflammation.

Dendritic cells (DCs) are increasingly recognized as important contributors to sepsis-associated immune dysfunction. As professional antigen-presenting cells, they bridge innate sensing and durable ...

Japan has cleared two pioneering stem-cell therapies, one for Parkinson’s disease and another for severe heart failure, according to the manufacturer and local media reports on Friday (March 6). The ...

The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...

Unlike transient innate immune activation, trained immunity is characterized by long-lasting but reversible functional reprogramming of monocytes, macrophages, natural killer (NK) cells, and ...

Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...

The squishy insoles in your favorite pair of sneakers help keep your joints safe from daily wear-and-tear, but over time, that cushioning wears down. The same goes for your cartilage—the fibrous ...